Biotronik Makes PROGRESS With Bioabsorbable Stent, Plans DES With Conor
This article was originally published in The Gray Sheet
Executive Summary
Biotronik will partner with Conor Medsystems to enhance its bioabsorbable metal stent with drug-eluting capabilities
You may also be interested in...
Bioabsorbable Stents Raise New Concerns For Investigators And Regulators
The next big thing in drug-eluting stents might be a simple disappearing act
Bioabsorbable Stents Raise New Concerns For Investigators And Regulators
The next big thing in drug-eluting stents might be a simple disappearing act
Conor CoStar Cleared For European Launch; Firm Modifies U.S. Trial Design
Conor Medsystems will launch its CoStar paclitaxel-eluting, cobalt-chromium coronary stent in Europe, having just received a CE mark, the firm said Feb. 17